Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 468
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05807880 | Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma | ||
| NCT04236362 | A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer | ||
| NCT06829784 | TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection | ||
| NCT04275050 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets | ||
| NCT05046847 | A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advanced Malignant Tumors | ||
| NCT06010537 | Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle | ||
| NCT06146751 | A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging for the Detection of Intracardiac Thrombus | ||
| NCT05830500 | Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma | ||
| NCT05306847 | Sintilimab Combined With Anlotinib Therapy for Initially Unresectable Non-small Cell Lung Cancer | ||
| NCT04180150 | A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B | ||
| NCT07043725 | A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer | ||
| NCT06431438 | Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of TQA3810 Tablets | ||
| NCT02574819 | Study of Methylnaltrexone in Opioid-Induced Constipation Patients | ||
| NCT06211751 | A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy | ||
| NCT07608666 | Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 Tablets | ||
| NCT07047365 | TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer | ||
| NCT05559242 | Pharmacokinetic Study of Anlotinib Hydrochloride Capsules in Healthy Subjects and Liver Dysfunction Patients | ||
| NCT03986073 | Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus | ||
| NCT06008405 | Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy | ||
| NCT06542614 | Treatment of Moderate to Severe Plaque Psoriasis | ||
| NCT04278820 | A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC) | ||
| NCT07179679 | A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors | ||
| NCT07113925 | A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies | ||
| NCT04619563 | A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer Patients | ||
| NCT04854668 | A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer | ||
| NCT03778138 | Study of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLC | ||
| NCT02996838 | A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics | ||
| NCT04073537 | Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung Cancer | ||
| NCT05192512 | Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers | ||
| NCT03983928 | Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer | ||
| NCT03855358 | A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC) | ||
| NCT06024915 | A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets | ||
| NCT04623333 | A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer | ||
| NCT06051565 | Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients | ||
| NCT05021367 | A Clinical Study of TQB3823 in Patients With Advanced Malignant Tumor | ||
| NCT03457844 | A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3 | ||
| NCT07367529 | A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection | ||
| NCT06415903 | A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer | ||
| NCT06821503 | Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C | ||
| NCT07083739 | A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults | ||
| NCT06768619 | Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State | ||
| NCT04956328 | Study of Obeticholic Acid(OCA) Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC) | ||
| NCT06931145 | Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer | ||
| NCT06561607 | A Clinical Trial of TQB2102 for Injection in the Treatment of HER2 Low-Expressing Recurrent/Metastatic Breast Cancer | ||
| NCT07633314 | A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary Disease | ||
| NCT03855384 | Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck(R/M SCCHN) | ||
| NCT05780567 | Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer | ||
| NCT07708272 | QT Interval/Corrected QT Interval (QT/QTc) Clinical Study to Evaluate the Cardiac Safety of TQ05105 Tablets in Healthy Participants | ||
| NCT02388919 | Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(ALTER0303) | ||
| NCT04923607 | Phase I Clinical Trial of TQC2731 Injection |
